Santhera Pharmaceuticals Holding AG | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
6.53 M |
Public Float |
- |
Santhera Pharmaceuticals Holding AG | |
Stock Exchange | SIX Swiss Exchange |
EPS |
CHF7.86 |
Market Cap |
CHF169.34 M |
Shares Outstanding |
11.16 M |
Public Float |
8.21 M |
Address |
Hohenrainstrasse 24 Pratteln Basel-Landschaft (Basle Country) 4133 Switzerland |
Employees | - |
Website | http://www.santhera.com |
Updated | 07/08/2019 |
Santhera Pharmaceuticals Holding AG is a pharmaceutical company. It engages in the development, marketing, and commercialization of pharmaceutical products for the treatment of neuro-ophthalmological, neuromuscular, and pulmonary diseases. It offers its products under the Raxone brands. |